Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment

NATerminatedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

May 15, 2021

Primary Completion Date

September 1, 2022

Study Completion Date

September 1, 2022

Conditions
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Stage I Lung Cancer AJCC v8Stage II Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8
Interventions
DEVICE

Attune™

Software as a medical device

DEVICE

Cerena™

Software as a medical device

Trial Locations (13)

11776

New York Cancer & Blood Specialists, Port Jefferson Station

44646

Tri-County Hematology and Oncology-Massillon, Massillon

59102

SCL Health, Billings

77030

MD Anderson, Houston

90720

Oncology Physicians Network Healthcare, Los Alamitos

91203

OPN Healthcare, Glendale

92373

Redlands Oncology, Redlands

98405

Northwest Medical Specialty, Tacoma

06360

Eastern CT Hematology and Oncology Associates, Norwich

61615-7828

Illinios Cancer Care, Peoria

02114

Massachusetts General Hospital, Boston

Michigan

"Rogel Cancer Center , University of Michigan"

08724

New Jersey Center for Cancer Research, Brick

Sponsors
All Listed Sponsors
lead

Blue Note Therapeutics

INDUSTRY

NCT04862195 - Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment | Biotech Hunter | Biotech Hunter